Media & Resources

Filter by

  • Type

  • Health area

  • Location

  • Topic

  • Year

  • Journal

  • Publication

  • Fact sheet & publication type

  • Clear all

Features

IAVI calls for innovative partnerships to sustain vaccine development at the World Vaccine Congress Europe 2025

October 30, 2025

IAVI’s experts underscored the value of equitable, regional partnerships in bringing new vaccines to market at this year’s convening in Amsterdam

Read more

IAVI Report

Dedication, not defeat

October 23, 2025

Drastic cuts to U.S. government funding imperil HIV/AIDS treatment and prevention programs and threaten HIV vaccine and cure research efforts across Africa. But the overarching view from East African researchers is one of resilience, not defeat.

Read more

IAVI Report

‘Of all the moments for science to slow down, this is not it.’

October 23, 2025

An HIV vaccine academy showcases the scientific talent of African researchers but is tempered by funding worries

Read more

Scientific Publications

Evidence required to evaluate the use of bacteriologically confirmed asymptomatic tuberculosis disease as a primary endpoint in prevention of tuberculosis disease vaccine licensure trials

Read more

Scientific Publications

Augmented humoral responses to HIV Env trimers delivered as transmembrane immunogens by self-replicating RNA

Read more

Scientific Publications

Neutralizing and binding antibodies are a correlate of risk of COVID-19 in the CoVPN 3008 study in people with HIV

Read more

Scientific Publications

Common cold embecovirus imprinting primes broadly neutralizing antibody responses to SARS-CoV-2 S2

Read more

Scientific Publications

Simultaneous priming of HIV broadly neutralizing antibody precursors to multiple epitopes by germline-targeting mRNA-LNP immunogens in mouse models

Read more